Steven Rutherford

Dr. Steven Rutherford

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2021 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
JSJiawei Sun
Jiawei Sun
SRSteven Rutherford
Steven Rutherford
TSThomas J. Silhavy
Thomas J. Silhavy
KHKerwyn Casey Huang
Kerwyn Casey Huang

11 December 2023 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
CMCraig R MacNair
Craig R MacNair
SRSteven Rutherford
Steven Rutherford
MTMan-Wah Tan
Man-Wah Tan

19 March 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KSKelly M. Storek
Kelly M. Storek
MAMarcy R. Auerbach
Marcy R. Auerbach
HSHanduo Shi
Handuo Shi
NGNatalie K. Garcia
Natalie K. Garcia
DSDawei Sun
Dawei Sun
SRSteven Rutherford
Steven Rutherford
The folding and insertion of integral β-barrel membrane proteins into the outer membrane of Gram-negative bacteria is required for viability and bacterial pathogenesis. Unfortunately, the lack of selective and potent modulators to dissect β-barrel folding in vivo has hampered our understanding of this fundamental biological process. Here, we characterize a monoclonal antibody that selectively inhibits an essential component of the Escherichia coli β-barrel assembly machine, BamA. In the absence of complement or other immune factors, the unmodified antibody MAB1 demonstrates bactericidal activity against an E. coli strain with truncated LPS. Direct binding of MAB1 to an extracellular BamA epitope inhibits its β-barrel folding activity, induces periplasmic stress, disrupts outer membrane integrity, and kills bacteria. Notably, resistance to MAB1-mediated killing reveals a link between outer membrane fluidity and protein folding by BamA in vivo, underscoring the utility of this antibody for studying β-barrel membrane protein folding within a living cell. Identification of this BamA antagonist highlights the potential for new mechanisms of antibiotics to inhibit Gram-negative bacterial growth by targeting extracellular epitopes. Significance The outer membrane of Gram-negative bacteria presents a formidable barrier to the discovery of new antibiotics needed to combat infections by multidrug-resistant bacteria. Targeting essential proteins or processes directly exposed to the environment could bypass this obstacle. Here, we describe a monoclonal antibody that selectively and potently antagonizes BamA, which folds and inserts integral outer membrane β-barrel proteins, by binding to a surface-exposed BamA epitope and, as a result, inhibits bacterial cell growth. Mechanisms of resistance to the antibody reveal that membrane fluidity affects BamA activity. This antibody validates the potential therapeutic strategy of targeting essential, exposed functions and provides a powerful tool for dissecting the fundamental process of folding integral membrane β-barrel proteins in vivo.

12 August 2020 in Nature
Verified
Journal Article
Closed access
PDF file
TCThomas Clairfeuille
Thomas Clairfeuille
KBKerry R. Buchholz
Kerry R. Buchholz
QLQingling Li
Qingling Li
EVErik Verschueren
Erik Verschueren
PLPeter Liu
Peter Liu
SRSteven Rutherford
Steven Rutherford

7 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
PWPaul White
Paul White
SHSamuel F. Haysom
Samuel F. Haysom
MIMatthew G. Iadanza
Matthew G. Iadanza
AHAnna J. Higgins
Anna J. Higgins
JMJonathan M. Machin
Jonathan M. Machin
SRSheena E. Radford
Sheena E. Radford
The folding of β-barrel outer membrane proteins (OMPs) in Gram-negative bacteria is catalysed by the β-barrel assembly machinery (BAM). How lateral opening in the β-barrel of the major subunit BamA assists in OMP folding, and the contribution of membrane disruption to BAM catalysis remain unresolved. Here, we use an anti-BamA monoclonal antibody fragment (Fab1) and two disulphide-crosslinked BAM variants (lid-locked (LL), and POTRA-5-locked (P5L)) to dissect these roles. Despite being lethal in vivo, we show that all complexes catalyse folding in vitro, albeit less efficiently than wild-type BAM. CryoEM reveals that while Fab1 and BAM-P5L trap an open-barrel state, BAM-LL contains a mixture of closed and contorted, partially-open structures. Finally, all three complexes globally destabilise the lipid bilayer, while BamA does not, revealing that the BAM lipoproteins are required for this function. Together the results provide insights into the role of BAM structure and lipid dynamics in OMP folding.

3 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KBKerry R. Buchholz
Kerry R. Buchholz
MRMike Reichelt
Mike Reichelt
MJMatthew C. Johnson
Matthew C. Johnson
SRSarah J. Robinson
Sarah J. Robinson
PSPeter A. Smith
Peter A. Smith
JQJohn G. Quinn
John G. Quinn
Polymyxins are gram-negative antibiotics that target lipid A, the conserved membrane anchor of lipopolysaccharide in the outer membrane. Despite their clinical importance, the molecular mechanisms underpinning polymyxin activity remain unresolved. Here, we use surface plasmon resonance to kinetically interrogate interactions between polymyxins and lipid A and derive a phenomenological model. Our analyses suggest a lipid A-catalyzed, three-state mechanism for polymyxins: transient binding, membrane insertion, and super-stoichiometric cluster accumulation with a long residence time. Accumulation also occurs for brevicidine, another lipid A-targeting antibacterial molecule. Lipid A modifications that impart polymyxin resistance and a non-bactericidal polymyxin derivative exhibit binding that does not evolve into long-lived species. We propose that transient binding to lipid A permeabilizes the outer membrane and cluster accumulation enables the bactericidal activity of polymyxins. These findings could establish a blueprint for discovery of lipid A-targeting antibiotics and provide a generalizable approach to study interactions with the gram-negative outer membrane.